Lactobacillus rhamnosus GG Improves Outcome in Experimental Pseudomonas aeruginosa Pneumonia
Authors:
- Ludmila KhailovaLKLudmila Khailova
- Christine H. BairdCBChristine H. Baird
- Aubri A. RushARAubri A. Rush
- Eoin N. McNameeEMEoin N. McNamee
- Paul E. WischmeyerPWPaul E. Wischmeyer
- 1 December 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Shock
- Vol. 40 (6) , 496-503
Abstract
Recent clinical trials show Lactobacillus rhamnosus GG (LGG) administration in critical illness has the potential to reduce nosocomial infections and improve clinical outcome. However, the mechanism(s) of LGG-mediated benefit following illness and injury remain elusive. The aim of this study was to determine the effect of LGG treatment on survival and lung injury in a mouse model of Pseudomonas aeruginosa-induced pneumonia. As increased T regulatory (Treg) cell numbers have been shown to improve outcome in experimental pneumonia, we examined the potential role of Treg cells in probiotic-mediated benefit. FVB/N mice were subjected to intratracheal injection of either P. aeruginosa or saline and received LGG or vehicle immediately before procedure. T regulatory cell responses in the lung were evaluated by polymerase chain reaction, Western blotting, and flow cytometry. Mice treated with LGG had significantly improved 7-day survival (P < 0.01) compared with saline-treated control pneumonia mice (55% LGG vs. 14% control). The survival advantage was associated with reduced bacterial counts in bronchoalveolar lavage and with decreased markers of the systemic inflammatory response and improved lung pathology in the probiotic group. Probiotic treatment influenced immune response in the lungs of mice with pneumonia as demonstrated by increased levels of Treg cell marker Foxp3. These data demonstrate that early administration of LGG improves outcome following P. aeruginosa-induced pneumonia. An effect of LGG on Treg cells may play a role in this protection.Keywords
This publication has 37 references indexed in Scilit:
- Probiotic Administration Reduces Mortality and Improves Intestinal Epithelial Homeostasis in Experimental SepsisAnesthesiology, 2013
- Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patientsCritical Care, 2008
- Probiotic administration in patients with ileal pouch–anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cellsInflammatory Bowel Diseases, 2008
- Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trialThe Lancet, 2008
- The re-emerging role of the intestinal microflora in critical illness and inflammation: why the gut hypothesis of sepsis syndrome will not go awayJournal of Leukocyte Biology, 2007
- Antibiotic prophylaxis to prevent nosocomial infections in patients in intensive care units: evidence that struggle to convince practising cliniciansInternal and Emergency Medicine, 2006
- Foxp3 programs the development and function of CD4+CD25+ regulatory T cellsNature Immunology, 2003
- Probiotics and inflammatory bowel disease: from fads and fantasy to facts and futureBritish Journal of Nutrition, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Prophylactic Lactobacillus GGReduces Antibiotic-Associated Diarrhea in Children With Respiratory Infections: A Randomized StudyPediatrics, 1999